Production (Stage)
Biosenta Inc.
ZRO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.71M | -1.64M | -5.01M | -4.98M | -4.86M |
| Total Depreciation and Amortization | 2.70K | 2.20K | 1.70K | 1.20K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.04M | 859.10K | 4.03M | 3.99M | 3.78M |
| Change in Net Operating Assets | 224.40K | 202.70K | 356.30K | 378.00K | 550.10K |
| Cash from Operations | -447.50K | -573.10K | -626.50K | -604.80K | -531.40K |
| Capital Expenditure | -18.50K | -- | -11.60K | -11.60K | -11.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.50K | -- | -11.60K | -11.60K | -11.60K |
| Total Debt Issued | 244.70K | 0.00 | 117.60K | 354.10K | 371.50K |
| Total Debt Repaid | -304.00K | -304.00K | -360.00K | -- | -- |
| Issuance of Common Stock | 600.00K | 934.70K | 934.70K | 334.70K | 334.70K |
| Repurchase of Common Stock | -359.90K | -359.90K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 359.50K | 511.10K | 151.20K | 151.40K | 151.20K |
| Cash from Financing | 391.60K | 574.30K | 620.80K | 620.90K | 633.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -74.50K | 1.10K | -17.20K | 4.70K | 90.70K |